MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Co-amoxiclav

Co-amoxiclav 250mg/125mg tablets

Incompatible

Stability notes for Co-amoxiclav 250mg/125mg tablets

Very moisture sensitive medicine. Original packaging may contain desiccant. Protect from light. Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Augmentin 375 mg tablets (Beecham Group plc) and Co-amoxiclav 250 mg/125 mg film-coated tablets (Sandoz Limited).

Suppliers (11) of Co-amoxiclav 250mg/125mg tablets
Augmentin 375mg tablets (GlaxoSmithKline UK Ltd)
Co-amoxiclav 250mg/125mg tablets (A A H Pharmaceuticals Ltd)
Co-amoxiclav 250mg/125mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amoxiclav 250mg/125mg tablets (Almus Pharmaceuticals Ltd)
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)
Co-amoxiclav 250mg/125mg tablets (Brown & Burk UK Ltd)
Co-amoxiclav 250mg/125mg tablets (Medihealth (Northern) Ltd)
Co-amoxiclav 250mg/125mg tablets (Milpharm Ltd)
Co-amoxiclav 250mg/125mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd)
Co-amoxiclav 250mg/125mg tablets (Sigma Pharmaceuticals Plc)

Co-amoxiclav 500mg/125mg tablets

Incompatible

Stability notes for Co-amoxiclav 500mg/125mg tablets

Very moisture sensitive medicine. Original packaging may contain desiccant. Protect from light. Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Augmentin 625mg tablets (Beecham Group plc) and Co-amoxiclav 500 mg/125 mg film-coated tablets (Sandoz Limited).

Suppliers (16) of Co-amoxiclav 500mg/125mg tablets
Augmentin 625mg tablets (GlaxoSmithKline UK Ltd)
Augmentin 625mg tablets (Sigma Pharmaceuticals Plc)
Co-amoxiclav 500mg/125mg tablets (A A H Pharmaceuticals Ltd)
Co-amoxiclav 500mg/125mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amoxiclav 500mg/125mg tablets (Almus Pharmaceuticals Ltd)
Co-amoxiclav 500mg/125mg tablets (Bristol Laboratories Ltd)
Co-amoxiclav 500mg/125mg tablets (Brown & Burk UK Ltd)
Co-amoxiclav 500mg/125mg tablets (Medihealth (Northern) Ltd)
Co-amoxiclav 500mg/125mg tablets (Medreich Plc)
Co-amoxiclav 500mg/125mg tablets (Milpharm Ltd)
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd)
Co-amoxiclav 500mg/125mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amoxiclav 500mg/125mg tablets (Rivopharm (UK) Ltd)
Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd)
Co-amoxiclav 500mg/125mg tablets (Sigma Pharmaceuticals Plc)
Co-amoxiclav 500mg/125mg tablets (Sun Pharma UK Ltd)

Co-amoxiclav 875mg/125mg tablets

No stability information

Stability notes for Co-amoxiclav 875mg/125mg tablets

There are no stability notes for this medicine.

Suppliers

Co-amoxiclav 875mg/125mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.